- Home
- RVPH vs JDZG Comparison
RVPH vs JDZG Comparison
Compare RVPH & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- JDZG
- Stock Information
- Founded
- RVPH 2006
- JDZG 2020
- Country
- RVPH United States
- JDZG China
- Employees
- RVPH N/A
- JDZG N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- JDZG Other Consumer Services
- Sector
- RVPH Health Care
- JDZG Real Estate
- Exchange
- RVPH Nasdaq
- JDZG Nasdaq
- Market Cap
- RVPH 33.4M
- JDZG 29.3M
- IPO Year
- RVPH N/A
- JDZG 2024
- Fundamental
- Price
- RVPH $1.22
- JDZG $0.72
- Analyst Decision
- RVPH Strong Buy
- JDZG
- Analyst Count
- RVPH 4
- JDZG 0
- Target Price
- RVPH $15.33
- JDZG N/A
- AVG Volume (30 Days)
- RVPH 661.2K
- JDZG 339.8K
- Earning Date
- RVPH 11-14-2024
- JDZG 11-26-2024
- Dividend Yield
- RVPH N/A
- JDZG N/A
- EPS Growth
- RVPH N/A
- JDZG N/A
- EPS
- RVPH N/A
- JDZG 0.06
- Revenue
- RVPH N/A
- JDZG $2,195,958.00
- Revenue This Year
- RVPH N/A
- JDZG N/A
- Revenue Next Year
- RVPH N/A
- JDZG N/A
- P/E Ratio
- RVPH N/A
- JDZG $11.97
- Revenue Growth
- RVPH N/A
- JDZG 52.08
- 52 Week Low
- RVPH $0.60
- JDZG $0.45
- 52 Week High
- RVPH $5.67
- JDZG $15.08
- Technical
- Relative Strength Index (RSI)
- RVPH 52.82
- JDZG N/A
- Support Level
- RVPH $1.09
- JDZG N/A
- Resistance Level
- RVPH $1.37
- JDZG N/A
- Average True Range (ATR)
- RVPH 0.15
- JDZG 0.00
- MACD
- RVPH 0.03
- JDZG 0.00
- Stochastic Oscillator
- RVPH 58.77
- JDZG 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About JDZG JIADE LIMITED Common stock
Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.